Michael C. Kaufmann to Become CFO of Cardinal Health; Jon Giacomin to Lead Pharmaceutical Segment
Cardinal Health has announced that Michael C. Kaufmann, 51, has been named Chief Financial Officer of the company effective 11 November 2014. This follows the previously announced planned retirement of current Chief Financial Officer Jeffrey W. Henderson, 49. Jon Giacomin, 49, has been named to the role of Chief Executive Officer of the pharmaceutical segment, currently held by Mike Kaufmann, also effective 11 November 2014.
"During the past 24 years, Mike has demonstrated a track record of high performance across many roles for Cardinal Health. His unique blend of financial acumen and extensive operational experience make him ideally suited to take the position of CFO," said George Barrett, Chairman and CEO of Cardinal Health. "We are excited to work with Mike in this new capacity. I'm thrilled that this move also allows us to bring Jon Giacomin into the pharmaceutical segment leadership role. We are privileged to have the opportunity to draw from the deep well of our internal talent."
Kaufmann has served in the role of CEO of Cardinal Health's pharmaceutical segment since 2009. He joined Cardinal Health in 1990 and held a number of senior operational, sales and finance positions. These positions included group president of the medical business of the former healthcare supply chain segment, after serving as the segment's CFO. Prior to joining Cardinal Health, Kaufmann had a successful career in audit and consulting with Arthur Andersen, formerly one of the nation's largest public accounting firms.
Kaufmann is a member of the executive committee of the boards of the Healthcare Distribution Management Association and the National Association of Chain Drug Stores, and a trustee at Ohio Northern University. Kaufmann is the executive sponsor of the Cardinal Health Women's Initiative Network Employee Resource Group, which is dedicated to fostering partnerships that create a great place for women to work and grow their careers, while building a sustainable competitive advantage for Cardinal Health.
To ensure a seamless transition, current Cardinal Health CFO Jeff Henderson will remain as an employee until his retirement just past the end of the fiscal year in August 2015. He will continue to have oversight for Cardinal Health China, in addition to working with the Cardinal Health leadership team on significant initiatives.
Jon Giacomin to Lead Pharmaceutical Segment
A 12-year veteran of Cardinal Health, Giacomin currently serves as president of US Pharmaceutical Distribution. Prior to this, he was Executive Vice President of Pharmaceutical Operations, where he was responsible for warehouse operations at 22 distribution centers and pharmaceutical packaging operations. Giacomin joined Cardinal Health in the pharmaceutical packaging business and served as its Vice President and General Manager before moving to the position of Senior Vice President of inventory management for the former Healthcare Supply Chain Services segment.
Prior to joining Cardinal Health, Giacomin held engineering and operating roles for Griffith Micro Science and Sterigenics. He also served as a lieutenant in the US nuclear Navy, where he held an engineering role.
He currently serves on the boards of trustees of the National Association of Chain Drug Stores Foundation and the Cardinal Health Foundation and as the executive sponsor of the Cardinal Health Veterans and Military Advocates Employee Resource Group.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance